Ionis Pharmaceuticals, Inc. (IONS): Price and Financial Metrics
GET POWR RATINGS... FREE!
IONS POWR Grades
- Value is the dimension where IONS ranks best; there it ranks ahead of 67.21% of US stocks.
- The strongest trend for IONS is in Growth, which has been heading up over the past 31 weeks.
- IONS ranks lowest in Sentiment; there it ranks in the 3rd percentile.
IONS Stock Summary
- IONS's went public 30.08 years ago, making it older than 83.48% of listed US stocks we're tracking.
- In terms of twelve month growth in earnings before interest and taxes, Ionis Pharmaceuticals Inc is reporting a growth rate of -162.33%; that's higher than merely 12.76% of US stocks.
- Revenue growth over the past 12 months for Ionis Pharmaceuticals Inc comes in at -26.21%, a number that bests just 15.01% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Ionis Pharmaceuticals Inc are RLAY, CLDR, NERV, DRIO, and VRAY.
- Visit IONS's SEC page to see the company's official filings. To visit the company's web site, go to www.ionispharma.com.
IONS Stock Price Chart Interactive Chart >
IONS Price/Volume Stats
|Current price||$37.93||52-week high||$64.37|
|Prev. close||$38.21||52-week low||$34.43|
|Day high||$38.48||Avg. volume||1,487,838|
|50-day MA||$39.45||Dividend yield||N/A|
|200-day MA||$49.30||Market Cap||5.35B|
Ionis Pharmaceuticals, Inc. (IONS) Company Bio
Ionis Pharmaceuticals, Inc., a RNA-targeted drug discovery and development company, focuses on developing drugs for patients with severe and rare diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
IONS Latest News Stream
|Loading, please wait...|
IONS Latest Social Stream
View Full IONS Social Stream
Latest IONS News From Around the Web
Below are the latest news stories about Ionis Pharmaceuticals Inc that investors may wish to consider to help them evaluate IONS as an investment opportunity.
CARLSBAD, Calif., June 10, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced that multiple presentations highlighting advances in its ATTR amyloidosis programs will be featured during the 2021 Peripheral Nerve Society
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced that multiple presentations highlighting advances in its ATTR amyloidosis programs will be featured during the 2021 Peripheral Nerve Society (PNS) Annual Meeting to be held virtually on June 12-13, and 25-27, 2021. Ionis' participation highlights the advancements it's made in developing novel antisense therapies for ATTR and underscores Ionis' commitment to this patient community.
New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy
New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated SPINRAZA treatment as pre-symptomatic infants maintained the ability to swallow after approximately 4 yearsAmong children and teens with later-onset SMA in the SHINE study, long-term treatment with SPINRAZA improved walking distance and reduced fatigue CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWI
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CARLSBAD, Calif., June 2, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced changes to its board of directors. Joseph Loscalzo, M.D., Ph.D., has been appointed chairman of the board and Allene M. Diaz has been appointed to the board. As previously announced,
IONS Price Returns
Continue Researching IONSWant to see what other sources are saying about Ionis Pharmaceuticals Inc's financials and stock price? Try the links below:
Ionis Pharmaceuticals Inc (IONS) Stock Price | Nasdaq
Ionis Pharmaceuticals Inc (IONS) Stock Quote, History and News - Yahoo Finance
Ionis Pharmaceuticals Inc (IONS) Stock Price and Basic Information | MarketWatch